Table 7 The outcome of control studies
Year/author | Clinical evaluation | Clinical evaluation based on the Ficat stage classification (mean difference/clinical success rate) | Radiographic evaluation (radiographic failure) | Complications /rate of complications | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean difference (scale used) | Clinical success rate | TIG | Other | TIG | Other | TIG | Other | |||||||||
TIG | Other | TIG | Other | I | II | III | IV | I | II | III | IV | |||||
2016/Zhaoa [21] | 26.08 (HHS) | 22.53 (HHS) | 95.65% | 76.00% | – | 21.16/100% | 32.37/90% | – | – | 17.34/92.31% | 28.07/58.33% | – | 8.7% | 24% | NA | NA |
2006/Yenb[22] | 2 (Charnley Functional Hip Score) | 3 (Charnley Functional Hip Score) | NA | NA | – | NA | NA | NA | – | NA | NA | NA | 43.59% | 18.18% | Mild wound-edge necrosis (2), damage of cutaneus femoris lateralis nerve (5), inguinal protrusion (1) 24.24% | Claw toe (1) 4.54% |
2003/Hasegawa c [23] | 14 (HHS) | 18 (HHS) | 58% | 68% | – | NA | NA | – | – | NA | NA | – | NA | NA | Mild wound-edge necrosis (3), damage of cutaneus femoris lateralis nerve (8) 42.31% | Early deep infection (1), trochanteric fracture (5), pseudarthrosis (1) 11.11% |